This website has been funded and developed by AbbVie and is intended for UK audiences only.

Make the most of MyMAP

Maximise discussions with your healthcare professional

Understanding the impact of your migraine is the first important step towards managing it. A big part of this essential stage in your migraine journey is to paint a picture of your experience for your healthcare professional to make a well-informed recommendation and assessment.

Through a series of questions about your daily life and experience, MyMAP helps you do just that. Simply complete the intuitive questionnaire and bring your results to your next appointment to discuss your experience.

Mythbusting migraine

Migraine is the 3rd most common health condition in the world1, but it’s surrounded by misconceptions.

Knowledge is power, so equip yourself with facts surrounding migraine and its impact.

Fact: Migraines are an officially recognised medical condition and are more severe than just headaches2

Myth: Migraines are
just bad headaches

Fact: Not drinking enough water can be a trigger of migraine3, but it’s entirely possible to be well hydrated and still suffer an attack.

Myth: If you get
migraines, you’re not
drinking enough water

Fact: Migraine is 2-3 times more common in women4-5, but can affect anyone regardless of sex. Undiagnosed migraine in men is common and can be a serious problem.5

Myth: Men don’t get
migraines

Can you tell fact from fiction? We have collected some key misconceptions surrounding migraine — watch the video below to learn more.

Common migraine myths: debunked

Sharpening your knowledge is a key first step towards understanding the impact migraine can have on your day-to-day life.

Click the button below to answer a series of intuitive questions about your experience of living with migraine and gain a better understanding of the ways it affects your daily life.

How you can benefit from using MyMAP

MyMAP can offer several benefits for people living with migraines, including:

  • Comprehensive tracking: MyMAP allows you to track various aspects of your migraines, including their frequency, duration, intensity, and associated symptoms. You can also record potential triggers such as specific foods, stress levels, sleep patterns, or weather changes
  • Enhanced communication with healthcare professionals: MyMAP empowers you to paint a picture of your migraine experience when meeting with your doctor. This improves communication, facilitates more effective discussions, and enables your healthcare professional to make more collaborative decisions regarding your treatment plan
  • Personalised treatment approach: With the information collected through MyMAP, you and your doctor can work together to develop a personalised treatment approach. By identifying patterns and triggers specific to your migraines, you can explore tailored strategies to try manage and prevent your migraines effectively
  • Better understanding of migraine patterns: MyMAP's tracking capabilities help you identify patterns related to your migraines. By analysing the data over time, you may discover recurring triggers, specific timeframes when migraines are more likely to occur, or factors that worsen or alleviate your symptoms
  • Empowerment and control: Utilising MyMAP may give you a sense of empowerment and control over your migraines. By actively tracking and managing your condition, you become an active participant in your healthcare journey. It allows you to take charge of your migraine management, make informed decisions, and confidently advocate for your needs

While MyMAP can be a valuable tool, it is important to consult with your doctor to receive an accurate diagnosis, guidance, and treatment recommendations. While MyMAP doesn’t replace or provide medical advice, you can leverage its benefits to optimise your migraine management and improve your overall quality of life.

References

1. What-is-migraine-factsheet. The Migraine trust - https://migrainetrust.org/understand-migraine/what-is-migraine/

2. ICHD-3 International Headache Society IHS Classification - https://ichd-3.org/1-migraine/

3. Khorsha, F., Mirzababaei, A., Togha, M., & Mirzaei, K. (2020). Association of drinking water and migraine headache severity. Journal of Clinical Neuroscience, 77, 81-84.

4. Vetvik, K. G., & MacGregor, E. A. (2017). Sex differences in the epidemiology, clinical features, and pathophysiology of migraine. The Lancet Neurology, 16(1), 76-87.

5. Scher, A. I., Wang, S. J., Katsarava, Z., Buse, D. C., Fanning, K. M., Adams, A. M., & Lipton, R. B. (2019). Epidemiology of migraine in men: results from the chronic migraine epidemiology and outcomes (CaMEO) study. Cephalalgia, 39(2), 296-305.

UK-ABBV-240317
November 2024

May 2023 | UK-ABBV-230064

This website has been developed and funded by AbbVie and is intended for UK audiences only. This resource is not intended to provide or replace expert medical advice.

@2024 AbbVie Ltd. AbbVie House, Vanwall Business Park, Maidenhead, Berkshire, SL6 4UB. UK Telephone: +44 (0) 1628 561 090. All rights reserved. Registered number: 08004972

Reporting of side effects: If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/. By reporting side effects, you can help provide more information on the safety of a medicine.